Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique

The goal of this operational research study is to develop, implement and test integrated CCS&PT and voluntary FP service delivery models to evaluate whether integrated service delivery can optimize uptake and health impact of both services. The study objectives and learning questions are listed below, along with key outcomes that will be measured.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Cervical Cancer Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Genital Neoplasms, Female Neoplasms Neoplasms by Site Urogenital Diseases Urogenital Neoplasms Uterine Cervical Diseases Uterine Cervical Neoplasms Uterine Diseases Uterine Neoplasms

Age range

30 year–49 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

M D Anderson Cancer Center

Houston, Texas, 77030, United States

About this study

Objectives:

The study objectives are outlined below:

To quantify the health impact of CCS&PT on the uptake of voluntary FP services.
To quantify the health impact of voluntary FP on the uptake of CCS&PT services.
To determine which promotional strategies are most effective to increase uptake of CCS&PT services.
To identify cost to deliver high quality CCS&PT services integrated into existing voluntary FP programs.
To determine client and provider acceptability of integrated CCS&PT and voluntary FP services using new screen and treat technologies.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Women 30 - 49 years or all women living with HIV
Not currently pregnant
Patients with a cervix (women who have undergone a total hysterectomy with removal of the cervix are not eligible)
Living in Maputo or Gaza
Willing and able to provide informed consent for services.

Exclusion criteria

Not meeting the inclusion criteria
Physical or mental impairment that inhibits participation in the study
Pregnant women

Treatment and study plan

HPV testing of women for cervical cancer screening

Behavioral

Women enrolled in this study will receive HPV testing for cervical cancer screening. They will be offered self-sampling. And also they will be offered voluntary Family Planning services, as appropriate.

Primary outcomes

Number of women who will undergo Cervical Cancer Screening by HPV testing

Time frame: through study completion, an average of 1 year

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Collaborators

Eduardo Mondlane University
Population Services International
William Marsh Rice University

Registry information

Important dates

Study start: 2020
Primary completion: 2027
Study completion: 2027
First posted: May 3, 2022
Registry last updated: May 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting